Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2020

Open Access 01-12-2020 | Tinnitus | Study protocol

Vestibular prognosis in idiopathic sudden sensorineural hearing loss with vestibular dysfunction treated with oral or intratympanic glucocorticoids: a protocol for randomized controlled trial

Authors: Weiming Hao, Liping Zhao, Huiqian Yu, Huawei Li

Published in: Trials | Issue 1/2020

Login to get access

Abstract

Background

Idiopathic sudden sensorineural hearing loss (ISSNHL) is a rapid-onset sensorineural hearing impairment with unclear etiology and unsatisfying treatment effects. Vestibular dysfunction has been considered as a poor indicator in the clinical manifestations and prognosis of ISSNHL, which occurred in approximately 28–57% cases. Glucocorticoids, administered through oral or intratympanic way, are currently regularly and standardly applied for ISSNHL to improve the hearing outcome. However, the vestibular prognosis of ISSNHL after routine treatments remains seldom explored. This study aims to compare the effectiveness of oral and intratympanic glucocorticoids in ISSNHL with vestibular dysfunction in terms of the pattern and trajectory of possible process of vestibular function recovery.

Methods/design

A randomized, outcome-assessor- and analyst-blinded, controlled, clinical trial (RCT) will be carried out. Seventy-two patients with ISSNHL complaining of vestibular dysfunction appearing as vertigo or imbalance will be recruited and randomized into either oral or intratympanic glucocorticoid therapy group with a 1:1 allocation ratio. The primary outcomes will be vestibular function outcomes assessed by sensory organization test, caloric test, video head impulse test, cervical vestibular evoked myogenic potential, and ocular vestibular evoked myogenic potential; the secondary outcomes include self-reported vestibular dysfunction symptoms; dizziness-related handicap, visual analogue scale for vertigo and tinnitus; and pure tone audiometry. Assessments of primary outcomes will be performed at baseline and at 4 and 8 weeks post-randomization, while assessments of secondary outcomes will be performed at baseline and 1, 2, 4, and 8 weeks post-randomization.

Discussion

Previous intervention studies of ISSNHL included only hearing outcomes, with little attention paid on the prognosis of vestibular dysfunction. This trial will be the first RCT study focusing on the progress and prognosis of vestibular dysfunction in ISSNHL. The efficacy of two commonly used therapies of glucocorticoids will be compared in both auditory and vestibular function fields, rather than in the hearing outcome alone.

Trial registration

ClinicalTrials.gov NCT03974867. Registered on 23 July 2019
Appendix
Available only for authorised users
Literature
1.
Chandrasekhar SS, Tsai Do BS, Schwartz SR, Bontempo LJ, Faucett EA, Finestone SA, Hollingsworth DB, Kelley DM, Kmucha ST, Moonis G, et al. Clinical practice guideline: sudden hearing loss (update). Otolaryngol Head Neck Surg. 2019;161(1_suppl):S1–S45.PubMed
2.
3.
Chau JK, Lin JR, Atashband S, Irvine RA, Westerberg BD. Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope. 2010;120(5):1011–21.PubMed
4.
Belal A Jr. Pathology of vascular sensorineural hearing impairment. Laryngoscope. 1980;90(11 Pt 1):1831–9.PubMed
5.
McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1979;88(5 Pt 1):585–9.PubMed
6.
Schuknecht HF, Kimura RS, Naufal PM. The pathology of sudden deafness. Acta Otolaryngol. 1973;76(2):75–97.PubMed
7.
Ciorba A, Corazzi V, Bianchini C, Aimoni C, Skarzynski H, Skarzynski PH, et al. Sudden sensorineural hearing loss: is there a connection with inner ear electrolytic disorders? A literature review. Int J Immunopathol Pharmacol. 2016;29(4):595–602.PubMedPubMedCentral
8.
Rauch SD. Clinical practice. Idiopathic sudden sensorineural hearing loss. N Engl J Med. 2008;359(8):833–40.PubMed
9.
Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA. 2011;305(20):2071–9.PubMed
10.
Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–6.PubMedPubMedCentral
11.
Shepard NT, Jacobson GP. The caloric irrigation test. Handb Clin Neurol. 2016;137:119–31.PubMed
12.
Yu L. Vestibular function examination technique. Xi’an: Air Force Medical University Press; 2013.
13.
Halmagyi GM, Chen L, MacDougall HG, Weber KP, McGarvie LA, Curthoys IS. The video head impulse test. Front Neurol. 2017;8:258.PubMedPubMedCentral
14.
15.
Colebatch JG, Rosengren SM, Welgampola MS. Vestibular-evoked myogenic potentials. Handb Clin Neurol. 2016;137:133–55.PubMed
16.
17.
Zhou YJ, Wu YZ, Cong N, Yu J, Gu J, Wang J, et al. Contrasting results of tests of peripheral vestibular function in patients with bilateral large vestibular aqueduct syndrome. Clin Neurophysiol. 2017;128(8):1513–8.PubMed
18.
Yollu U, Uluduz DU, Yilmaz M, et al. Vestibular migraine screening in a migraine-diagnosed patient population, and assessment of vestibulocochlear function. Clin Otolaryngol. 2017;42:225–33.PubMed
19.
Liu J, Zhou RH, Liu B, Leng YM, Liu JJ, Liu DD, et al. Assessment of balance and vestibular functions in patients with idiopathic sudden sensorineural hearing loss. J Huazhong Univ Sci Technolog Med Sci. 2017;37(2):264–70.PubMed
20.
Zhou YJ, Yu J, Wu YZ, Tian L, Han Z, Wang J, et al. The potential dysfunction of otolith organs in patients after mumps infection. PLoS One. 2017;12(7):e0181907.PubMedPubMedCentral
21.
22.
Atay G, Kayahan B, Cinar BC, Sarac S, Sennaroglu L. Prognostic factors in sudden sensorineural hearing loss. Balkan Med J. 2016;33(1):87–93.PubMedPubMedCentral
23.
Jacobson GP, Newman CW. The development of the dizziness handicap inventory. Arch Otolaryngol Head Neck Surg. 1990;116(4):424–7.PubMed
24.
Mutlu B, Serbetcioglu B. Discussion of the dizziness handicap inventory. J Vestib Res. 2013;23(6):271–7.PubMed
25.
Lionello M, Staffieri C, Breda S, Turato C, Giacomelli L, Magnavita P, et al. Uni- and multivariate models for investigating potential prognostic factors in idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol. 2015;272(8):1899–906.PubMed
26.
Zhang Y, Liu B, Wang Y, Zhou Y, Wang R, Gong J, Peng X. Analysis of reliability and validity of the Chinese version of dizziness handicap inventory (DHI) [in Chinese]. Chin J Otorhinolaryngol Head Neck Surg. 2015;50(9):738–43.
27.
Dannenbaum E, Chilingaryan G, Fung J. Visual vertigo analogue scale: an assessment questionnaire for visual vertigo. J Vestib Res. 2011;21(3):153–9.PubMed
28.
Johnson C. Measuring pain. Visual analog scale versus numeric pain scale: what is the difference? J Chiropr Med. 2005;4(1):43–4.PubMedPubMedCentral
29.
Waljee AK, Rogers MA, Lin P, Singal AG, Stein JD, Marks RM, et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017;357:j1415.PubMedPubMedCentral
30.
Yu H, Li H. Association of vertigo with hearing outcomes in patients with sudden sensorineural hearing loss: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2018;144(8):677–83.PubMedPubMedCentral
31.
Yu H, Li H. Vestibular dysfunctions in sudden sensorineural hearing loss: a systematic review and meta-analysis. Front Neurol. 2018;9:45.PubMedPubMedCentral
32.
Erdfelder E, Faul F, Buchner A. GPOWER: a general power analysis program. Behav Res Methods Instrum Comput. 1996;28(1):1–11.
33.
Ben-David J, Luntz M, Podoshin L, Sabo E, Fradis M. Vertigo as a prognostic sign in sudden sensorineural hearing loss. Int Tinnitus J. 2002;8(2):127–8.PubMed
34.
Niu X, Zhang Y, Zhang Q, Xu X, Han P, Cheng Y, et al. The relationship between hearing loss and vestibular dysfunction in patients with sudden sensorineural hearing loss. Acta Otolaryngol. 2016;136(3):225–31.PubMed
35.
Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery, Society of Otorhinolaryngology Head and Neck Surgery, Chinese Medical Association. Guideline of diagnosis and treatment of sudden deafness (2015). Chin J Otorhinolaryngol Head Neck Surg. 2015;50(6):443–7.
36.
Trune DR, Canlon B. Corticosteroid therapy for hearing and balance disorders. Anat Rec (Hoboken). 2012;295(11):1928–43.
37.
Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: II. A meta-analysis. Arch Otolaryngol Head Neck Surg. 2007;133(6):582–6.PubMed
38.
Crane RA, Camilon M, Nguyen S, Meyer TA. Steroids for treatment of sudden sensorineural hearing loss: a meta-analysis of randomized controlled trials. Laryngoscope. 2015;125(1):209–17.PubMed
39.
Nosrati-Zarenoe R, Hultcrantz E. Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: randomized triple-blind placebo-controlled trial. Otol Neurotol. 2012;33(4):523–31.PubMed
40.
Batuecas-Caletrio A, Yanez-Gonzalez R, Sanchez-Blanco C, Perez PB, Gonzalez-Sanchez E, Sanchez LA, et al. Glucocorticoids improve acute dizziness symptoms following acute unilateral vestibulopathy. J Neurol. 2015;262(11):2578–82.PubMed
41.
Strupp M, Zingler VC, Arbusow V, Niklas D, Maag KP, Dieterich M, et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med. 2004;351(4):354–61.PubMed
42.
Kantner C, Gurkov R. Characteristics and clinical applications of ocular vestibular evoked myogenic potentials. Hear Res. 2012;294(1–2):55–63.PubMed
43.
Wrisley DM, Stephens MJ, Mosley S, Wojnowski A, Duffy J, Burkard R. Learning effects of repetitive administrations of the sensory organization test in healthy young adults. Arch Phys Med Rehabil. 2007;88(8):1049–54.PubMed
44.
Chiu CW, Lee TC, Hsu PC, Chen CY, Chang SC, Chiang JY, et al. Efficacy and safety of acupuncture for dizziness and vertigo in emergency department: a pilot cohort study. BMC Complement Altern Med. 2015;15:173.PubMedPubMedCentral
Metadata
Title
Vestibular prognosis in idiopathic sudden sensorineural hearing loss with vestibular dysfunction treated with oral or intratympanic glucocorticoids: a protocol for randomized controlled trial
Authors
Weiming Hao
Liping Zhao
Huiqian Yu
Huawei Li
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04579-6

Other articles of this Issue 1/2020

Trials 1/2020 Go to the issue

Letter

Effects of Licorice on clinical symptoms and laboratory signs in moderately ill patients with pneumonia from COVID-19: A structured summary of a study protocol for a randomized controlled trial

Letter

Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial

Study protocol

Phase II, open-label, multicenter trial of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study

Study protocol

The TOPSY pessary self-management intervention for pelvic organ prolapse: a study protocol for the process evaluation

Study protocol

Acupuncture treatment on the motor area of the scalp for motor dysfunction in children with cerebral palsy: study protocol for a multicenter randomized controlled trial

Letter

Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial